Effects of growth hormone replacement on cortisol metabolism in hypopituitary patients treated with cortisone acetate

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 61, Issue 4, 2001, Pages 277-286

  Beentjes, J A M ^a   Kerstens, M N ^a   Dullaart, R P F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

11 HSD; Cortisol; Cortisone; Cortisone acetate; Growth hormone; Hypopituitarism

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALLOTETRAHYDROCORTISOL; CORTISONE ACETATE; GROWTH HORMONE; HYDROCORTISONE; PLACEBO; TETRAHYDROCORTISOL; UNCLASSIFIED DRUG;

ADRENAL FUNCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG METABOLISM; DRUG WITHDRAWAL; ENZYME ACTIVITY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HORMONE URINE LEVEL; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADULT; AGED; CORTISONE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; HYPOPITUITARISM; MALE; MIDDLE AGED; WATER;

EID: 0034972679     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510152379003     Document Type: Article

References (34)

1. 11 beta-Hydroxysteroid dehydrogenase: Implications for clinical medicine
2. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess
3. A new isoform of 11 beta-hydroxysteroid dehydrogenase in aldosterone target cells
4. Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform
5. Purification and characterization of the corticosteroid 11β-dehydrogenase component of the rat liver 11β-hydroxysteroid dehydrogenase complex
6. Expression of 11 beta-hydroxysteroid dehydrogenase using recombinant vaccinia virus
7. Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome
8. 11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: Effect of physicochemical and hormonal manipulations
9. The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization
10. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol
11. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man
12. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo
13. Clinical aspects of growth hormone deficiency in adults
14. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. Growth Hormone Research Society Scientific Committee
15. Sexual dimorphism of hepatic 11 beta-hydroxysteroid dehydrogenase in the rat: The role of growth hormone patterns
16. Sex- and tissue- specific regulation of 11 beta-hydroxysteroid dehydrogenase mRNA
17. Effect of growth hormone, insulin and dexamethasone on 11 beta-hydroxysteroid dehydrogenase activity on a primary culture of rat hepatocytes
18. Modulation of 11 beta-hydroxysteroid dehydrogenase isoenzymes by growth hormone and insulin-like growth factor: In vivo and in vitro studies
19. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults
20. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: Evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity
21. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients
22. Evaluation of adrenal function in patients with hypothalamic and pituitary disorders: Comparison of serum cortisol, urinary free cortisol and the human-corticotrophin releasing hormone test with the insulin tolerance test
23. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia
24. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the Growth Hormone Research Society Workshop on adult growth hormone deficiency
25. One year growth hormone replacement therapy does not alter colonic epithelial cell proliferation in growth hormone deficient adults
26. Assessment of fat-free mass using bioelectrical impedance measurements of the human body
27. Detection of 3 beta-hydroxysteroid dehydrogenase deficiency in a newborn by means of urinary steroid analysis
28. Intercomparison of four methods for measuring cortisol production
29. Special problems in the radioimmunoassay of plasma aldosterone without prior extraction and purification
30. Lack of relationship between 11β-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients
31. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
32. The daily cortisol production reinvestigated in healthy men. The serum and urinary cortisol production rates are not significantly different
33. Cortisol metabolism in human obesity: Impaired cortisone→cortisol conversion in subjects with central adiposity
34. Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy